mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.02 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |